Bromide

Bromide

SCHEMBL23535338

Cc1ccc2c[n+](Cc3ccccc3)ccc2c1.[Br-]

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 4/20 0.60
CHKA known ✓ P35790 2/20 0.45
BCHE P06276 3/20 0.59
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 3/20 0.51
RAB9A P51151 1/20 0.51
LMNA P02545 4/20 0.45
HTT P42858 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
CYP2A6 P11509 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
KMT2A Q03164 1/20 0.43
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3601825 0.81 ACHE (0.89) ACHEBCHE
SCHEMBL1127774 0.79 ACHE (0.85) ACHEBCHE
SCHEMBL23259016 0.79 ACHE (0.57) ACHEBCHEALDH1A1RAB9ALMNA
SCHEMBL19102953 0.78 ACHE (0.56) ACHEBCHEALDH1A1KDM4ERAB9A
Hydrochloric Acid SCHEMBL8870693 0.78 ACHE (0.81) ACHEBCHELMNA
SCHEMBL19102924 0.77 ACHE (0.50) ACHEBCHEALDH1A1KDM4ERAB9A
Bromide SCHEMBL1757103 0.74 ALDH1A1 (0.72) ACHEBCHEALDH1A1KDM4ERAB9A
SCHEMBL23259284 0.74 BCHE (0.50) ACHEBCHEALDH1A1KDM4ELMNA
SCHEMBL23258819 0.73 ACHE (0.57) ACHEBCHEALDH1A1LMNACHKA
Bromide SCHEMBL17105097 0.73 LMNA (0.62) ACHEALDH1A1KDM4ERAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4076459-B1 PRMT5 INHIBITORS MERCK SHARP & DOHME LLC (US) 2026-04-29 EP disclosed
US-12595248-B2 PRMT5 inhibitors MERCK SHARP & DOHME LLC (US) 2026-04-07 US disclosed
US-20230108114-A1 PRMT5 INHIBITORS MERCK SHARP & DOHME LLC (US) 2023-04-06 US disclosed
EP-4076459-A1 PRMT5 INHIBITORS Merck Sharp & Dohme LLC (US) 2022-10-26 EP disclosed
WO-2021126728-A1 PRMT5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2021-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595248-B2 PRMT5 inhibitors PRMT5, PRMT1, PRMT6 ACHE 4595/4885CHKA 927/4885BCHE 2681/4885
US-20230108114-A1 PRMT5 INHIBITORS PRMT5, PRMT1, PRMT3 ACHE 3205/4885CHKA 2228/4885BCHE 1013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.